Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas

Stephen Atkin, H. E. Burnett, V. L. Green, M. C. White, M. Lombard

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective. The human pituitary gland is affected selectively by conditions associated with iron deposition, but the mechanisms for this are unknown. In this study we have determined whether the transferrin receptor, which mediates iron uptake by cells, could be detected immunocytochemically in human pituitary adenomas in vitro. Patients. Data were derived from 35 patients undergoing transsphenoidal surgery and included 13 with clinically non-functioning adenomas, 15 with acromegaly, 4 prolactinomas, 2 patients with Cushing's disease and one patient with Nelson's syndrome. Measurements. Transferrin receptor immunopositivity was determined for each adenoma in dispersed cell culture using a specific monoclonal antibody. Results. Eight of 13 clinically functionless adenomas showed immunopositive transferrin receptor expression, whilst adenomas from 15 patients with acromegaly, 4 prolactinomas, 2 Cushing's syndrome and one patient with Nelson's syndrome were negative. The eight transferrin receptor positive tumours were gonadotrophinomas and accounted for eight of the nine tumours which secreted and immunostained for FSH; all eight also secreted and immunostained for LH. Conclusions. These findings may reflect a special requirement for iron by gonadotrophin secreting cells in comparison to other pituitary cell types and this could underlie the reasons why in the normal pituitary these cells are especially susceptible to malfunction in iron overload syndromes such as genetic haemochromatosis and β-thalassaemia.

Original languageEnglish
Pages (from-to)467-471
Number of pages5
JournalClinical Endocrinology
Volume44
Issue number4
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Transferrin Receptors
Pituitary Neoplasms
Adenoma
Nelson Syndrome
Prolactinoma
Acromegaly
Iron
Pituitary ACTH Hypersecretion
Iron Overload
Thalassemia
Hemochromatosis
Cushing Syndrome
Pituitary Gland
Gonadotropins
Neoplasms
Cell Culture Techniques
Monoclonal Antibodies

ASJC Scopus subject areas

  • Endocrinology

Cite this

Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas. / Atkin, Stephen; Burnett, H. E.; Green, V. L.; White, M. C.; Lombard, M.

In: Clinical Endocrinology, Vol. 44, No. 4, 1996, p. 467-471.

Research output: Contribution to journalArticle

Atkin, Stephen ; Burnett, H. E. ; Green, V. L. ; White, M. C. ; Lombard, M. / Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas. In: Clinical Endocrinology. 1996 ; Vol. 44, No. 4. pp. 467-471.
@article{8248ca81c5b049bd82028991c0a3cf46,
title = "Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas",
abstract = "Objective. The human pituitary gland is affected selectively by conditions associated with iron deposition, but the mechanisms for this are unknown. In this study we have determined whether the transferrin receptor, which mediates iron uptake by cells, could be detected immunocytochemically in human pituitary adenomas in vitro. Patients. Data were derived from 35 patients undergoing transsphenoidal surgery and included 13 with clinically non-functioning adenomas, 15 with acromegaly, 4 prolactinomas, 2 patients with Cushing's disease and one patient with Nelson's syndrome. Measurements. Transferrin receptor immunopositivity was determined for each adenoma in dispersed cell culture using a specific monoclonal antibody. Results. Eight of 13 clinically functionless adenomas showed immunopositive transferrin receptor expression, whilst adenomas from 15 patients with acromegaly, 4 prolactinomas, 2 Cushing's syndrome and one patient with Nelson's syndrome were negative. The eight transferrin receptor positive tumours were gonadotrophinomas and accounted for eight of the nine tumours which secreted and immunostained for FSH; all eight also secreted and immunostained for LH. Conclusions. These findings may reflect a special requirement for iron by gonadotrophin secreting cells in comparison to other pituitary cell types and this could underlie the reasons why in the normal pituitary these cells are especially susceptible to malfunction in iron overload syndromes such as genetic haemochromatosis and β-thalassaemia.",
author = "Stephen Atkin and Burnett, {H. E.} and Green, {V. L.} and White, {M. C.} and M. Lombard",
year = "1996",
language = "English",
volume = "44",
pages = "467--471",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas

AU - Atkin, Stephen

AU - Burnett, H. E.

AU - Green, V. L.

AU - White, M. C.

AU - Lombard, M.

PY - 1996

Y1 - 1996

N2 - Objective. The human pituitary gland is affected selectively by conditions associated with iron deposition, but the mechanisms for this are unknown. In this study we have determined whether the transferrin receptor, which mediates iron uptake by cells, could be detected immunocytochemically in human pituitary adenomas in vitro. Patients. Data were derived from 35 patients undergoing transsphenoidal surgery and included 13 with clinically non-functioning adenomas, 15 with acromegaly, 4 prolactinomas, 2 patients with Cushing's disease and one patient with Nelson's syndrome. Measurements. Transferrin receptor immunopositivity was determined for each adenoma in dispersed cell culture using a specific monoclonal antibody. Results. Eight of 13 clinically functionless adenomas showed immunopositive transferrin receptor expression, whilst adenomas from 15 patients with acromegaly, 4 prolactinomas, 2 Cushing's syndrome and one patient with Nelson's syndrome were negative. The eight transferrin receptor positive tumours were gonadotrophinomas and accounted for eight of the nine tumours which secreted and immunostained for FSH; all eight also secreted and immunostained for LH. Conclusions. These findings may reflect a special requirement for iron by gonadotrophin secreting cells in comparison to other pituitary cell types and this could underlie the reasons why in the normal pituitary these cells are especially susceptible to malfunction in iron overload syndromes such as genetic haemochromatosis and β-thalassaemia.

AB - Objective. The human pituitary gland is affected selectively by conditions associated with iron deposition, but the mechanisms for this are unknown. In this study we have determined whether the transferrin receptor, which mediates iron uptake by cells, could be detected immunocytochemically in human pituitary adenomas in vitro. Patients. Data were derived from 35 patients undergoing transsphenoidal surgery and included 13 with clinically non-functioning adenomas, 15 with acromegaly, 4 prolactinomas, 2 patients with Cushing's disease and one patient with Nelson's syndrome. Measurements. Transferrin receptor immunopositivity was determined for each adenoma in dispersed cell culture using a specific monoclonal antibody. Results. Eight of 13 clinically functionless adenomas showed immunopositive transferrin receptor expression, whilst adenomas from 15 patients with acromegaly, 4 prolactinomas, 2 Cushing's syndrome and one patient with Nelson's syndrome were negative. The eight transferrin receptor positive tumours were gonadotrophinomas and accounted for eight of the nine tumours which secreted and immunostained for FSH; all eight also secreted and immunostained for LH. Conclusions. These findings may reflect a special requirement for iron by gonadotrophin secreting cells in comparison to other pituitary cell types and this could underlie the reasons why in the normal pituitary these cells are especially susceptible to malfunction in iron overload syndromes such as genetic haemochromatosis and β-thalassaemia.

UR - http://www.scopus.com/inward/record.url?scp=0029880128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029880128&partnerID=8YFLogxK

M3 - Article

C2 - 8706315

AN - SCOPUS:0029880128

VL - 44

SP - 467

EP - 471

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 4

ER -